Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs.

Published in: Expert opinion on drug delivery (2020)

Formulation of protein-drug nanocarriers via non-covalent self-assembly can be advantageous as a promising strategy for efficient and safe tumor-targeted delivery of anti-cancer drugs compared to the conventional nano-fabrication technologies.

Keyphrases

drug delivery
drug induced
protein protein
amino acid
binding protein
high throughput
adverse drug